LEP and cancer: High subcutaneous adiposity leads to elevated leptin levels (hyperleptinemia), a condition that promotes the secretion of inflammatory factors and further activates immune cells, thus affecting the tumor immune microenvironment and supporting cancer cell growth and migration.